Liberation Bioindustries makes Etan Bendheim CEO and moves co-founder Mark Warner to CTO

Liberation Bioindustries/Richmond Precision Fermentation Plant

Chief business officer Etan Bendheim became CEO and Mark Warner moved to chief technology officer as the Richmond plant entered late-stage construction. The company said over half of the plant's nameplate capacity is under contract or in late-stage agreements, with production expected in 2026.

• Plant: 600,000 L with a dedicated downstream processing unit
• Planning for a Saudi Arabian plant with Topian continues